-
1481por Adamczick, Charlotte, Dierig, Alexa, Welzel, Tatjana, Schifferli, Alexandra, Blum, Johannes, Ritz, Nicole“…BACKGROUND: Leishmaniasis is endemic in many countries worldwide, with a prevalence of 12 million people infected, and an estimated annual incidence of 500 000 visceral leishmaniasis cases. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1482por Chapman, Lloyd A. C., Jewell, Chris P., Spencer, Simon E. F., Pellis, Lorenzo, Datta, Samik, Chowdhury, Rajib, Bern, Caryn, Medley, Graham F., Hollingsworth, T. Déirdre“…BACKGROUND: Visceral leishmaniasis (VL) is characterised by a high degree of spatial clustering at all scales, and this feature remains even with successful control measures. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1483por Carnielli, Juliana B.T., Crouch, Kathryn, Forrester, Sarah, Silva, Vladimir Costa, Carvalho, Sílvio F.G., Damasceno, Jeziel D., Brown, Elaine, Dickens, Nicholas J., Costa, Dorcas L., Costa, Carlos H.N., Dietze, Reynaldo, Jeffares, Daniel C., Mottram, Jeremy C.“…BACKGROUND: Miltefosine has been used successfully to treat visceral leishmaniasis (VL) in India, but it was unsuccessful for VL in a clinical trial in Brazil. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1484
-
1485“…BACKGROUND: Liposomal amphotericin B (L-amB, AmBisome®) is popular for off-label use in the treatment of cutaneous leishmaniasis (CL) using dosing of 3 mg/kg/day for days 1–5, 8, 9, or days 1–5, 10 with reported clinical cure rates of 46–84%. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1486por Mastroianni, Antonio, Gaibani, Paolo, Rossini, Giada, Vocale, Caterina, Re, Maria Carla, Ravaglia, Gianfranco, Sambri, Vittorio, Varani, Stefania“…BACKGROUND: The management of visceral leishmaniasis (VL) in HIV-infected patients is often complex with patients experiencing higher mortality rates, more toxic side effects and a higher possibility of treatment failure and relapse than HIV-negative individuals with VL. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1487por Hasnain, Md Golam, Nath, Proggananda, Maruf, Shomik, Nabi, Shah Golam, Hossain, A. F. M. Akhtar, Ahmed, Be-Nazir, Mondal, Dinesh, Basher, Ariful“…OBJECTIVE: Based on studies in India (as there was no studies from outside India) amphotericin B deoxycholate has been considered as a backup drug for treatment of visceral leishmaniasis. However, treatment response and adverse effect to anti-leishmanial drugs may vary across different populations and in Bangladesh the effect to amphotericin B deoxycholate for treatment of visceral leishmaniasis is still unknown. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1488“…Visceral leishmaniasis (VL) remains a serious public health problem in China. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1489por Galgamuwa, Lahiru Sandaruwan, Sumanasena, Buthsiri, Iddawela, Devika, Wickramasinghe, Susiji, Yatawara, Lalani“…BACKGROUND: Cytokines play a vital role in the host immune response to infection by initiating the healing process and/or accelerating the progression of the disease in cutaneous leishmaniasis (CL). Very little evidence is available on cytokine profiles and their regulatory function in CL patients in Sri Lanka. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1490por Galvão, Endi Lanza, Pedras, Mariana Junqueira, Cota, Gláucia Fernandes, Rabello, Ana, Simões, Taynãna César“…METHODOLOGY: Between December 2015 and May 2017, 100 patients with localized cutaneous leishmaniasis were interviewed at a leishmaniasis referral center in Brazil. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1491por TANASE, Oana Irina, DARABAN, Constantin, VELESCU, Elena, BOGHEAN, Dragos, BOCANETI-DARABAN, Florentina“…Leishmaniasis is a zoonotic parasitosis caused by a diphasic protozoan of the genus Leishmania. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1492“…Future implications for the American healthcare system regarding malaria and leishmaniasis are also presented.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1493por dos Santos, Anna Raquel Ribeiro, Serufo, Ângela Vieira, Figueiredo, Maria Marta, Godoi, Lara Carvalho, Vitório, Jéssica Gardone, Marcelino, Andreza Pain, de Avelar, Daniel Moreira, Rodrigues, Fernandes Tenório Gomes, Machado-Coelho, George Luiz Lins, Medeiros, Fernanda Alvarenga Cardoso, Jerônimo, Selma Maria Bezerra, de Oliveira, Edward José, Nascimento, Frederico Crepaldi, Teixeira, Santuza Maria Ribeiro, Gazzinelli, Ricardo Tostes, Nagem, Ronaldo Alves Pinto, Fernandes, Ana Paula“…BACKGROUND: Visceral Leishmaniasis (VL) is an infectious disease that is a significant cause of death among infants aged under 1 year and the elderly in Brazil. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1494por Kuna, Anna, Gajewski, Michał, Bykowska, Martyna, Pietkiewicz, Halina, Olszański, Romuald, Myjak, Przemysław“…INTRODUCTION: Leishmaniasis is a vector-borne infection endemic in 98 countries. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1495por Sulaiman, Amel Abdalrhim, Elmadhoun, Wadie Mohammed, Noor, Sufian Khalid, Bushara, Sarra Osman, Almobarak, Ahmed O., Awadalla, Heitham, Farag, Elmoubashar, Ahmed, Mohamed H.“…BACKGROUND: Human cutaneous leishmaniasis (CL) is an endemic disease in many parts of Sudan. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1496por Rasheed, Zafar, Ahmed, Ahmed A., Salem, Tarek, Al-Dhubaibi, Mohammed S., Al Robaee, Ahmad A., Alzolibani, Abdullateef A.“…The cutaneous leishmaniasis (CL) is a most common form of leishmaniasis and it remains to be a major public health issue in Saudi Arabia. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1497por Chakravarty, Jaya, Hasker, Epco, Kansal, Sangeeta, Singh, Om Prakash, Malaviya, Paritosh, Singh, Abhishek Kumar, Chourasia, Ankita, Singh, Toolika, Sudarshan, Medhavi, Singh, Akhil Pratap, Singh, Bhawana, Singh, Rudra Pratap, Ostyn, Bart, Fakiola, Michaela, Picado, Albert, Menten, Joris, Blackwell, Jenefer M., Wilson, Mary E., Sacks, David, Boelaert, Marleen, Sundar, Shyam“…We aimed to identify serological, immunological and genetic markers for progression from L. donovani infection to clinical Visceral Leishmaniasis (VL). METHODS: We enrolled all residents >2 years of age in 27 VL endemic villages in Bihar (India). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1498por Shrestha, Mitesh, Khatri-Chhetri, Medha, Poudel, Ram Chandra, Maharjan, Jyoti, Dumre, Shyam Prakash, Manandhar, Krishna Das, Pandey, Basu Dev, Pun, Sher Bahadur, Pandey, Kishor“…BACKGROUND: Visceral Leishmaniasis (VL) is caused by a protozoan parasite Leishmania donovani that is transmitted to humans by an infected female sandfly, Phlebotomus argentipes. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1499por Kumar, Prabin, Misra, Pragya, Yadav, Narendra Kumar, Joshi, Sumit, Sahasrabuddhe, Amogh A., Dube, Anuradha, Rishi, Narayan, Mitra, Dipendra Kumar“…However, the prophylactic role of IL-17 in visceral leishmaniasis has still not been validated. In the present study, we evaluated the prophylactic efficacy of IL-17A and interferon (IFN)-γ in Leishmania donovani-challenged Balb/c mice. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1500por Hussein, Nawfal R., Balatay, Amer A., Saleem, Zana S. M., Hassan, Shiraz M., Assafi, Mahde S., Sheikhan, Ramzy Sh., Amedi, Farasheen R., Hafzullah, Shivan S., Hafzullah, Mahmood S., Xedr, Abdulkareem M., Zebary, Mohamed T., Aqrawi, Hindreen A.“…Leishmaniasis is caused by protozoan parasites of the genus Leishmania and is a major health problem in various parts of the world. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto